Extended-spectrum antibiotics for community-acquired pneumonia with a low risk for drug-resistant pathogens.
Kobayashi H, Shindo Y, Kobayashi D, Sakakibara T, Murakami Y, Yagi M, Matsuura A, Sato K, Matsui K, Emoto R, Yagi T, Saka H, Matsui S, Hasegawa Y; Central Japan Lung Study Group.
Kobayashi H, et al. Among authors: yagi m, yagi t.
Int J Infect Dis. 2022 Nov;124:124-132. doi: 10.1016/j.ijid.2022.09.015. Epub 2022 Sep 16.
Int J Infect Dis. 2022.
PMID: 36116670
Free article.